New Elite Feature: Screen & Chart at the same time

Tarsus Pharmaceuticals, Inc

Contributing Author

Recent Articles by Tarsus Pharmaceuticals, Inc

May-14	Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans TARS GlobeNewswire
May-07	Tarsus to Participate in Upcoming Investor Conferences TARS GlobeNewswire
Apr-29	Tarsus to Report First Quarter 2026 Financial Results on Wednesday, May 6, 2026 TARS GlobeNewswire
Mar-31	Tarsus Doses First Participant in Calliope, A Phase 2 Clinical Trial of TP-05 (lotilaner), a Novel Investigational Oral Tablet for the Potential Prevention of Lyme Disease TARS GlobeNewswire
Mar-23	TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus TARS GlobeNewswire
Feb-26	Tarsus to Participate in Upcoming Investor Conferences TARS GlobeNewswire
Feb-23	Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements TARS +7.79% TARS GlobeNewswire
Feb-18	Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors TARS GlobeNewswire
Feb-17	Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 TARS GlobeNewswire
Nov-24	Tarsus to Participate in Upcoming Investor Conference TARS GlobeNewswire
Nov-05	Tarsus to Participate in Upcoming Investor Conference TARS GlobeNewswire
Nov-04	Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements TARS GlobeNewswire
Oct-28	Tarsus to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 TARS GlobeNewswire
Aug-27	Tarsus to Participate in Upcoming Investor Conferences TARS GlobeNewswire
Aug-06	Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements TARS +15.15% TARS GlobeNewswire
Jul-30	Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 TARS GlobeNewswire
May-29	Tarsus to Participate in Upcoming Investor Conferences TARS GlobeNewswire
May-08	Tarsus to Participate in Upcoming Investor Conferences TARS -5.05% TARS GlobeNewswire
May-01	Tarsus Reports First Quarter 2025 Financial Results and Recent Business Achievements TARS -5.84% TARS GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)